Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2004 2
2005 3
2006 2
2007 3
2008 2
2009 1
2010 6
2011 9
2012 6
2013 8
2014 9
2015 5
2016 2
2017 3
2018 5
2019 2
2020 3
2021 2
2022 1
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Personalized Biomarker-Based Umbrella Trial for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: KCSG HN 15-16 TRIUMPH Trial.
Keam B, Hong MH, Shin SH, Heo SG, Kim JE, Ahn HK, Lee YG, Park KU, Yun T, Lee KW, Kim SB, Lee SC, Kim MK, Cho SH, Oh SY, Park SG, Hwang S, Nam BH, Kim S, Kim HR, Yun HJ; KCSG TRIUMPH Investigators. Keam B, et al. Among authors: yun t. J Clin Oncol. 2024 Feb 10;42(5):507-517. doi: 10.1200/JCO.22.02786. Epub 2023 Sep 12. J Clin Oncol. 2024. PMID: 37699162 Clinical Trial.
A Phase II Trial of Rivoceranib, an Oral Vascular Endothelial Growth Factor Receptor 2 Inhibitor, for Recurrent or Metastatic Adenoid Cystic Carcinoma.
Hanna GJ, Ahn MJ, Muzaffar J, Keam B, Bowles DW, Wong DJ, Ho AL, Kim SB, Worden F, Yun T, Meng X, Van Tornout JM, Conlan MG, Kang H. Hanna GJ, et al. Among authors: yun t. Clin Cancer Res. 2023 Nov 14;29(22):4555-4563. doi: 10.1158/1078-0432.CCR-23-1030. Clin Cancer Res. 2023. PMID: 37643133 Free PMC article. Clinical Trial.
Guidelines for Cancer Care during the COVID-19 Pandemic in South Korea.
Lee JB, Jung M, Kim JH, Kim BH, Kim Y, Kim YS, Kim BC, Kim J, Moon SH, Park KU, Park M, Park HJ, Sim SH, Yoon HM, Lee SJ, Lee E, Chun JY, Chung YK, Jung SY, Chung J, Lee ES, Chung HC, Yun T, Rha SY. Lee JB, et al. Among authors: yun t. Cancer Res Treat. 2021 Apr;53(2):323-329. doi: 10.4143/crt.2020.1256. Epub 2021 Mar 15. Cancer Res Treat. 2021. PMID: 33721486 Free PMC article.
Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinoma.
Kim DH, Lim Y, Ock CY, Park G, Park S, Song H, Ma M, Mostafavi M, Kang EJ, Ahn MJ, Lee KW, Kwon JH, Yang Y, Choi YH, Kim MK, Ji JH, Yun T, Kim SB, Keam B. Kim DH, et al. Among authors: yun t. Head Neck. 2023 Dec;45(12):3086-3095. doi: 10.1002/hed.27537. Epub 2023 Oct 13. Head Neck. 2023. PMID: 37828867 Clinical Trial.
Reference intervals for circulating angiogenic cytokines.
Kong SY, Lee HL, Eom HS, Park WS, Yun T, Kim HJ, Nam BH, Seong MW, Lee DH. Kong SY, et al. Among authors: yun t. Clin Chem Lab Med. 2008;46(4):545-50. doi: 10.1515/CCLM.2008.092. Clin Chem Lab Med. 2008. PMID: 18298351
66 results